Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IRAK4 Kinase Inhibitory Activity Assay from US Patent US20240132473: "SULFOXIMIDE SUBSTITUTED INDAZOLE IRAK4 KINASE INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF"
Assay data:40 Active, 35 Activity ≤ 1 nM, 40 Activity ≤ 1 µM, 40 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Biological Assays against IRAK4 from US Patent US20240043405: "POTENT AND SELECTIVE IRREVERSIBLE INHIBITORS OF IRAK1"
Assay data:10 Active, 1 Activity ≤ 1 µM, 21 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Human whole blood IRAK4 degradation flow assay from US Patent US11352350: "IRAK degraders and uses thereof"
Assay data:44 Active, 45 Activity ≤ 1 µM, 45 Tested
IRAK4 Invitrogen Lab (UK) kinase screen (BI)
Assay data:1 Tested
SummaryRelated BioAssays by Target
Inhibition of IRAK4 (unknown origin) at 10 uM by biochemical hotspot kinase assay
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of human GST-tagged IRAK4 incubated for 30 mins in presence of ATP by fluorescent polarization assay
Assay data:5 Active, 2 Activity ≤ 1 nM, 5 Activity ≤ 1 µM, 5 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of IRAK4 (unknown origin) at 1 uM relative to control
Assay data:3 Tested
Inhibition of IRAK4 (unknown origin) at 0.1 uM relative to control
Inhibition of human IRAK4 using biotinylated FGLARFSRFAGSSPSQSSMVARTQTVRGT peptide as substrate incubated for 1 hr in presence of ATP by ELISA assay
Assay data:22 Active, 22 Activity ≤ 1 µM, 23 Tested
Binding affinity to CRBN/IRAK4 in human PBMC cells assessed as inhibition of R848-stimulated IL-6 production incubated for 24 hrs by MSD analysis
Assay data:7 Active, 10 Activity ≤ 1 µM, 10 Tested
Binding affinity to CRBN/IRAK4 in human PBMC cells assessed as inhibition of R848-stimulated IL-6 production by measuring maximal efficacy incubated for 24 hrs by MSD analysis relative to control
Assay data:10 Tested
Binding affinity to CRBN/IRAK4 in human PBMC cells assessed as inhibition of LPS-stimulated IL-6 production incubated for 24 hrs by MSD analysis
Assay data:6 Active, 10 Activity ≤ 1 µM, 10 Tested
Binding affinity to CRBN/IRAK4 in human PBMC cells assessed as inhibition of LPS-stimulated IL-6 production by measuring maximal efficacy incubated for 24 hrs by MSD analysis relative to control
Inhibition of IRAK4 (unknown origin) by Ambit kinase assay
Assay data:4 Tested
Inhibition of IRAK4 (unknown origin)
Inhibition of IRAK4 (unknown origin) phosphorylation by cell based assay
Assay data:34 Active, 27 Activity ≤ 1 µM, 35 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on